Our current knowledge of the role that periostin plays in many fibrotic processes, together with encouraging, albeit preliminary data from SSc patients, suggests that periostin may be a promising biomarker of disease complications in SSc. The gene discussed is POSTN; the disease is systemic sclerosis.